- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Amylin Pharmaceuticals Inc.
Headquarters: San Diego, CA, United States of America
Website: N/A
Year Founded: 1987
Status: Acquired
BioCentury | Mar 7, 2025
Product Development
Could amylin outshine GLP-1 in obesity?
If the preclinical data translate to the clinic, amylin has a good chance to supplant GLP-1 for the overweight to moderate obesity population
BioCentury | Nov 21, 2024
Finance
Versant-backed Pep2Tango taking four-way agonist to clinic for obesity
Program designed to reduce weight while sparing muscle mass, GI effects headed for IND next year
BioCentury | Jan 18, 2023
Politics, Policy & Law
Hit by the Clinton cyclone
Clintonomic uncertainty slams the window down: BioCentury’s 30th anniversary collection
BioCentury | Apr 29, 2022
Product Development
April 28 Quick Takes: Pfizer enrolling DMD trial after FDA lifts hold
Plus FDA approves AZ’s Ultomiris for gMG and updates from Gilead, Cytovia and more
BioCentury | Mar 23, 2020
Product Development
March 23 Quick Takes: Venclexta combo hits in AML; plus Jardiance rebuffed, Zolgensma approved in Japan and Zealand-Boehringer
BioCentury | Jun 6, 2019
Company News
Management tracks: Grail taps Juno founder Bishop as CEO; plus Clovis, OncoCyte, Calico
BioCentury | May 20, 2017
Strategy
Henri: N of 1
How the late Genzyme CEO Henri Termeer created the Orphan drug industry
BioCentury | Dec 17, 2015
Strategy
San Diego ceiling
New academic leadership in San Diego aims to amp up cluster's translational power
Items per page:
1 - 10 of 751